PROGNOSDX HEALTH
PrognosDx Health, Inc., a biotechnology company, develops and commercializes epigenetic tests based on histone modification patterns. The company also provides services, such as pharmaceutical research-clinical sample analysis, clinical patient sample analysis tests for other cancers, and prostate cancer patient prognosis test. Its products are used in the development of cancer prognostic assays, therapeutic response prediction assays, and research tools and reagents. The company’s tissue-based global cellular histone biomarkers are prognostic for various cancers, such as prostate, pancreatic, breast, bladder, kidney, gastrics, colon, and lung cancer. PrognosDx Health, Inc. was incorporated in 2008 and is based in Palo Alto, California.
PROGNOSDX HEALTH
Social Links:
Industry:
Biotechnology Health Care Medical Device
Founded:
2008-01-01
Address:
Palo Alto, California, United States
Country:
United States
Website Url:
http://www.prognosdx.com
Total Employee:
1+
Status:
Closed
Contact:
5105270804
Email Addresses:
[email protected]
Total Funding:
10 K USD
Technology used in webpage:
Wix Wix DNS Web.com Email
Similar Organizations
Aragon Surgical
Aragon Surgical develops and commercializes surgical products that reduce operative time and improve patient safety.
Control Medical Technology
Control Medical Technology develops and commercializes patient care devices for physicians, nurses, and technicians.
Healeon Medical, Inc.
Develop and commercialize next generation protocols that improve isolation of regenerative cells.
Sierra Surgical
Sieraa Surgical develops minimally-invasive surgical systems based on female sterilization technologies.
Sonosite
Sonosite innovates, develops and commercializes ultrasound machines used in the clinical and pre-clinical markets.
Xillix
Xillix has develops and commercializes medical imaging technologies for detection and localization of cancer.
Current Employees Featured
Founder
Official Site Inspections
http://www.prognosdx.com
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.186
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "PrognosDx Health"
PrognosDx Health - Crunchbase Company Profile & Funding
PrognosDx Health, Inc., a biotechnology company, develops and commercializes epigenetic tests based on histone modification patterns. The company also provides services, such as …See details»
PrognosDx Health - PitchBook
PrognosDx Health General Information Description. Operator of a biotechnology company intended to develop drugs for cancer treatment. The company's drugs are developed for …See details»
Company Profile for PrognosDx Health, Inc. | Business Wire
Apr 1, 2011 Company: PrognosDx Health, Inc. Headquarters Address: 530 University Ave. Mail Box # 203 Palo Alto, CA 94301See details»
PrognosDx Health - Products, Competitors, Financials, Employees ...
PrognosDx's tissue-based global cellular histone biomarkers have been confirmed by researchers to be prognostic for multiple cancers and demonstrated by scientific founders in a study …See details»
PrognosDx Health Board of Directors Appoints Joseph J. Vallner, …
Nov 1, 2013 Palo Alto, CA. – October 24, 2013 – PrognosDx Health, Inc., a leader in the field of cancer epigenetics, today announced that industry veteran Joseph J. Vallner ...See details»
PrognosDx Health - Contacts, Employees, Board Members
Organization. PrognosDx Health . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. About. …See details»
PrognosDx Health - Funding, Financials, Valuation & Investors
PrognosDx Health has raised a total of . obfuscated. obfuscated. in funding over 1 round. This was a Debt Financing round raised on May 17, 2011. Unlock for free . ... How much funding …See details»
PrognosDx Health | VentureRadar
PrognosDx’s technology is based on a breakthrough discovery that revealed the role of chemical changes to specific sites on histone proteins as powerful prognostic markers for many cancers …See details»
Real-World Health Data Marketplace | Prognos Health
TRUSTED. Harmonized and enriched data from diverse sources that trust Prognos to implement rigorous data validation and verification processes to ensure accuracy, completeness, and appropriate use.See details»
GeneDx and Prognos Health Announce Strategic Partnership to …
Jul 19, 2023 Partnership allows commercial biopharma companies to leverage real-time data within comprehensive Prognos Marketplace to provide available treatment options for patientsSee details»
PrognosDx, Accium team on histone biomarker tests
Oct 26, 2011 PrognosDx Health is combining its epigenetics technology with Accium BioSciences' accelerator mass spectronomy platform to develop predictive histone biomarker …See details»
PrognosDx Health - Tech Stack, Apps, Patents & Trademarks
PrognosDx Health uses 14 technology products and services including HTML5, GreenSock Animation Platform, and Google Fonts, according to G2 Stack. PrognosDx Health is actively …See details»
GeneDx and Prognos partner to boost treatment for rare diseases
Jul 20, 2023 GeneDx chief transformation officer Kareem Saad stated: “Patients with rare diseases oftentimes have to endure a diagnostic odyssey of approximately eight years, …See details»
GeneDx and Prognos Health Announce Strategic Partnership to …
Jul 19, 2023 --GeneDx, a leader in delivering improved health outcomes through genomic and clinical insights, and Prognos Health, the largest real-world integrated data marketplace, today …See details»
PrognosDx Health - Crunchbase
PrognosDx Health develops and commercializes epigenetic tests based on histone modification patterns.See details»
PrognosDx Health Board of Directors Appoints Joseph J ... - BioSpace
Oct 29, 2013 PrognosDx’s Board of Directors Member and Executive Director of the Molecular Medicine Research Institute Edward P. Amento, M.D., said, "We are honored to have Dr. …See details»
GeneDx and Prognos Health Announce Strategic Partnership to …
Jul 19, 2023 Partnership allows commercial biopharma companies to leverage real-time data within comprehensive Prognos Marketplace to provide available treatment options for …See details»
Working At PrognosDx Health: Company Overview and Culture
Learn about working at PrognosDx Health from employee reviews and detailed data on culture, salaries, demographics, management, financial, and more. Find out what it's like to work at …See details»
PrognosDx, MMRI Ink Epigenetics R&D Collaboration
Jul 8, 2013 NEW YORK (GenomeWeb News) – PrognosDx Health and the Molecular Medicine Research Institute announced recently a broad collaborative R&D agreement aimed at using …See details»
GeneDx and Prognos Health Announce Strategic Partnership to
Jul 19, 2023 NEW YORK and STAMFORD, Conn., July 19, 2023 (GLOBE NEWSWIRE) -- GeneDx, a leader in delivering improved health outcomes through genomic and clinical …See details»